Figure 1From: Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programmeKaplan-Meier estimates of progression free survival and overall survival by patient ages. A. Progression-free survival. B. OS, overall survival; PFS, progression-free survival.Back to article page